Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Apr;7(4):220-9.
doi: 10.1038/nrclinonc.2010.17. Epub 2010 Mar 16.

Treatment of painful bone metastases

Affiliations
Review

Treatment of painful bone metastases

Dirk Rades et al. Nat Rev Clin Oncol. 2010 Apr.

Abstract

Bone metastases are the most common cause of cancer-related pain. Radiotherapy is a safe and effective therapy and is well established for such a situation. A fractionation regimen with a short overall treatment time (< or =1 week) would be preferred if it was as effective as longer courses (2-4 weeks). Randomized clinical trials and meta-analyses have demonstrated that single-fraction radiotherapy with 1 x 8 Gy is as effective for pain relief as multi-fraction regimens such as 5 x 4 Gy in 1 week or 10 x 3 Gy in 2 weeks. Re-irradiation for recurrent pain in the irradiated region is required more often after single-fraction radiotherapy than multi-fraction radiotherapy; however, re-irradiation following single-fraction radiotherapy is safe and effective. Thus, 1 x 8 Gy is considered the standard regimen for uncomplicated painful bone metastases without pathological fractures or spinal cord compression. Multi-fraction radiotherapy results in significantly better remineralization of the osteolytic bone than single-fraction radiotherapy. Remineralization is important for preventing or treating pathological fractures. Multi-fraction long-course radiotherapy results in fewer recurrences of spinal-cord compression within the irradiated spinal region. Thus, long-course multi-fraction radiotherapy should be reserved for patients with a relatively favorable survival prognosis.

PubMed Disclaimer

References

    1. J Clin Oncol. 2007 Apr 10;25(11):1423-36 - PubMed
    1. J Natl Cancer Inst. 2005 Jun 1;97(11):798-804 - PubMed
    1. Semin Oncol. 1993 Jun;20(3 Suppl 2):44-8 - PubMed
    1. Cancer. 2003 Apr 15;97(8):2013-8 - PubMed
    1. J Clin Oncol. 2002 Sep 1;20(17):3719-36 - PubMed